We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$3.1M
(+2.6%)
Cap. Flow
+$30.4M
Cap. Flow
% of AUM
25.24%
Top 10 Holdings %
Top 10 Hldgs %
19.44%
Holding
209
New
93
Increased
10
Reduced
42
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.43M |
| 2 |
JPMorgan Chase
JPM
|
+$2.49M |
| 3 |
Visa
V
|
+$2.46M |
| 4 |
Pfizer
PFE
|
+$2.46M |
| 5 |
Analog Devices
ADI
|
+$1.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revvity
RVTY
|
+$1.28M |
| 2 |
LyondellBasell Industries
LYB
|
+$1.25M |
| 3 |
Fastenal
FAST
|
+$1.23M |
| 4 |
Qualcomm
QCOM
|
+$1.21M |
| 5 |
Occidental Petroleum
OXY
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Financials | 18.53% |
| 3 | Energy | 14.69% |
| 4 | Industrials | 14.26% |
| 5 | Healthcare | 13.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Blackrock
BLK
$178B
| $623K | 0.52% |
+1,133
| New | +$742K |
|
77
DoubleVerify
DV
$2.03B
| $617K | 0.51% |
+22,577
| New | +$582K |
|
78
Scorpio Tankers
STNG
$3.72B
| $614K | 0.51% |
14,608
-14,768
| -50% | -$588K |
|
79
Morgan Stanley
MS
$338B
| $613K | 0.51% |
+7,770
| New | +$655K |
|
80
Ryder
R
$9.92B
| $601K | 0.5% |
+7,973
| New | +$607K |
|
|
ESTE
81
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $600K | 0.5% |
48,725
-17,458
| -26% | -$237K |
|
|
MRSH
82
Marsh
MRSH
$91.3B
| $590K | 0.49% |
+3,956
| New | +$635K |
|
83
W.W. Grainger
GWW
$61.3B
| $587K | 0.49% |
1,201
-1,037
| -46% | -$546K |
|
84
Cullen/Frost Bankers
CFR
$10.3B
| $586K | 0.49% |
4,436
-4,358
| -50% | -$571K |
|
85
Associated Banc-Corp
ASB
$6.02B
| $583K | 0.48% |
+29,057
| New | +$584K |
|
86
Bank of America
BAC
$448B
| $583K | 0.48% |
+19,304
| New | +$645K |
|
87
Hubbell
HUBB
$27.5B
| $581K | 0.48% |
2,608
-3,068
| -54% | -$644K |
|
88
Neurocrine Biosciences
NBIX
$16.5B
| $576K | 0.48% |
+5,428
| New | +$551K |
|
89
Old National Bancorp
ONB
$10.3B
| $573K | 0.48% |
+34,834
| New | +$582K |
|
90
Core & Main
CNM
$8.73B
| $571K | 0.47% |
25,121
-19,340
| -43% | -$452K |
|
91
Patterson-UTI
PTEN
$4.22B
| $571K | 0.47% |
+48,961
| New | +$700K |
|
92
Banner Corp
BANR
$2.47B
| $566K | 0.47% |
+9,593
| New | +$579K |
|
93
Northern Oil and Gas
NOG
$2.58B
| $565K | 0.47% |
+20,620
| New | +$582K |
|
94
Northwest Bancshares
NWBI
$2.29B
| $563K | 0.47% |
+41,680
| New | +$580K |
|
95
Grid Dynamics Holdings
GDYN
$630M
| $561K | 0.47% |
+29,984
| New | +$568K |
|
96
International Seaways
INSW
$4.41B
| $561K | 0.47% |
+15,981
| New | +$442K |
|
|
HCP
97
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $557K | 0.46% |
17,319
-13,960
| -45% | -$482K |
|
|
NEX
98
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $557K | 0.46% |
75,280
-26,343
| -26% | -$231K |
|
99
Medtronic
MDT
$116B
| $556K | 0.46% |
+6,890
| New | +$619K |
|
100
Becton Dickinson
BDX
$49.4B
| $555K | 0.46% |
+2,491
| New | +$620K |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Alpha DNA Investment Management held 209 positions worth $120M, up 2.6% from $117M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Alpha DNA Investment Management deployed $30.4M of net new capital in Q3 2022, opening 93 new positions and adding to 10 existing holdings. Its largest new stake was ExxonMobil: 37,550 shares worth $3.28M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $988K trimmed.
- Alpha DNA Investment Management's largest Q3 2022 buy was ExxonMobil: 37,550 shares worth $3.28M.
- Alpha DNA Investment Management added most to Analog Devices in Q3 2022, an estimated $1.93M increase.
- Alpha DNA Investment Management's biggest Q3 2022 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $988K.
- Alpha DNA Investment Management fully exited Revvity in Q3 2022, selling an estimated $1.28M.
- Alpha DNA Investment Management's ten largest holdings make up 19% of its $120M portfolio in Q3 2022.
- Alpha DNA Investment Management opened 93 new positions and closed 64 in Q3 2022.
- Alpha DNA Investment Management's portfolio value rose 2.6% quarter-over-quarter to $120M.
Based on Alpha DNA Investment Management's 13F filing for Q3 2022, filed 15 Nov 2022.